Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOHN A CECE

Allopathic & Osteopathic Physicians Otolaryngology Otolaryngology/Facial Plastic Surgery

NPI
1437198553
CMS profile
20441
Location
WAYNE, NJ

General Payments · PY2018–2024

$3,279.37

  • Reported across 156 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$842.27

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $842.27 35

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
AXOGEN $175.56 2
OptiNose US, Inc. $136.51 9
AERIN MEDICAL INC. $95.27 3
QAPEL MEDICAL INC $94.90 1
GlaxoSmithKline, LLC. $94.35 6
GENZYME CORPORATION $89.59 5
Regeneron Healthcare Solutions, Inc. $80.16 5
Kaleo, Inc. $33.86 2
CSL Behring $25.10 1
Takeda Pharmaceuticals U.S.A., Inc. $16.97 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $169.02 8
PY2019 $620.04 21
PY2020 $66.45 4
PY2021 $197.70 13
PY2022 $790.98 42
PY2023 $592.91 33
PY2024 $842.27 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AERIN MEDICAL INC. $33.88 01/05/2024 Food and Beverage Undisputed 01/23/2026 1144653665 CMS
AERIN MEDICAL INC. $31.39 07/25/2024 Food and Beverage Undisputed 01/23/2026 1144647964 CMS
AERIN MEDICAL INC. $30.00 09/18/2024 Food and Beverage Undisputed 01/23/2026 1144648410 CMS
AXOGEN $79.79 08/01/2024 Food and Beverage Undisputed 01/23/2026 1143640188 CMS
AXOGEN $95.77 08/09/2024 Food and Beverage Undisputed 01/23/2026 1143640419 CMS
CSL Behring $25.10 08/27/2024 Food and Beverage Undisputed 01/23/2026 1134642511 CMS
GENZYME CORPORATION $15.99 03/06/2024 Food and Beverage Undisputed 01/23/2026 1139708847 CMS
GENZYME CORPORATION $15.23 04/03/2024 Food and Beverage Undisputed 01/23/2026 1139708857 CMS
GENZYME CORPORATION $20.97 05/23/2024 Food and Beverage Undisputed 01/23/2026 1139708869 CMS
GENZYME CORPORATION $17.99 10/16/2024 Food and Beverage Undisputed 01/23/2026 1139708931 CMS
GENZYME CORPORATION $19.41 10/31/2024 Food and Beverage Undisputed 01/23/2026 1139708943 CMS
GlaxoSmithKline, LLC. $14.84 02/29/2024 Food and Beverage Undisputed 01/23/2026 1116708839 CMS
GlaxoSmithKline, LLC. $14.42 03/23/2024 Food and Beverage Undisputed 01/23/2026 1116645835 CMS
GlaxoSmithKline, LLC. $16.22 06/27/2024 Food and Beverage Undisputed 01/23/2026 1116343966 CMS
GlaxoSmithKline, LLC. $18.25 08/22/2024 Food and Beverage Undisputed 01/23/2026 1116711161 CMS
GlaxoSmithKline, LLC. $15.95 10/30/2024 Food and Beverage Undisputed 01/23/2026 1116100936 CMS
GlaxoSmithKline, LLC. $14.67 12/12/2024 Food and Beverage Undisputed 01/23/2026 1116395728 CMS
kaleo, Inc. $16.34 06/20/2024 Food and Beverage Undisputed 01/23/2026 1126626069 CMS
kaleo, Inc. $17.52 09/19/2024 Food and Beverage Undisputed 01/23/2026 1126626071 CMS
Optinose US, Inc. $22.25 02/13/2024 Food and Beverage Undisputed 01/23/2026 1142179204 CMS
Optinose US, Inc. $24.17 04/17/2024 Food and Beverage Undisputed 01/23/2026 1142179238 CMS
Optinose US, Inc. $1.79 04/18/2024 Food and Beverage Undisputed 01/23/2026 1142179220 CMS
Optinose US, Inc. $15.67 06/11/2024 Food and Beverage Undisputed 01/23/2026 1142179254 CMS
Optinose US, Inc. $16.27 07/09/2024 Food and Beverage Undisputed 01/23/2026 1142179290 CMS
Optinose US, Inc. $16.27 08/06/2024 Food and Beverage Undisputed 01/23/2026 1142179284 CMS
Optinose US, Inc. $15.67 09/17/2024 Food and Beverage Undisputed 01/23/2026 1142179276 CMS
Optinose US, Inc. $20.14 10/23/2024 Food and Beverage Undisputed 01/23/2026 1142179300 CMS
Optinose US, Inc. $4.28 10/24/2024 Food and Beverage Undisputed 01/23/2026 1142179260 CMS
QAPEL MEDICAL INC $94.90 01/24/2024 Food and Beverage Undisputed 01/23/2026 1147398372 CMS
Regeneron Healthcare Solutions, Inc. $15.53 01/03/2024 Food and Beverage Undisputed 01/23/2026 1114020528 CMS
Regeneron Healthcare Solutions, Inc. $15.53 02/01/2024 Food and Beverage Undisputed 01/23/2026 1114020530 CMS
Regeneron Healthcare Solutions, Inc. $15.53 05/06/2024 Food and Beverage Undisputed 01/23/2026 1114020532 CMS
Regeneron Healthcare Solutions, Inc. $17.10 08/13/2024 Food and Beverage Undisputed 01/23/2026 1114020534 CMS
Regeneron Healthcare Solutions, Inc. $16.47 09/23/2024 Food and Beverage Undisputed 01/23/2026 1114020536 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.97 09/25/2024 Food and Beverage Undisputed 01/23/2026 1137505506 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.